Ophelia is the industry leader in opioid use disorder treatment
Combining telehealth and medication (MOUD), we drive clinical outcomes, expand access, and save lives.
Ophelia allows payors to expand access, improve outcomes, and reduce costs. Our treatment model retains patients in treatment 2x longer than traditional models.
Ophelia treats your patients with the gold-standard OUD care and is partnered by many major insurance plans, including Medicaid and Medicare.
For health systems
Utilize Ophelia within your existing ecosystem to improve outcomes, increase satisfaction, and decrease costs. We also support workforce development through custom educational programs.
Improve outcomes and remove barriers to OUD treatment by partnering with Ophelia
94% of patients are engaged in early treatment in care (HEDIS measure: Engagement of Alcohol or other Drug Treatment Measure), more than 5x the national average. Ophelia consistently demonstrates high engagement and retention rates, ensuring that patients receive the care that impacts their lives the most.
Ophelia solves some of the biggest treatment barriers like geographical access, affordability, and clinical access by offering 100% remote visits, partnering with major commercial, Medicaid, and Medicare providers, and educating the future workforce through partnerships with Yale, UPenn, and SAMHSA.
Spend less than any other treatment program
Total cost per patient per month for the first three months post OUD diagnosis*
Comprehensive care built around your patient's needs
• Pharmacy support
• Resource navigator
• Complex case management
• Remote urine drug testing
• Self service patient portal